1. Aichberger F (1996) Sozialgesetzbuch, Reichsversicherungsordnung. C. H. Beck’sche Verlagsbuchhandlung, München
2. Barr JT, Schumacher GE (1996) Using decision analysis to conduct pharmacoeconomic studies. In: Spilker B (eds) Quality of Life and Pharmacoeconomics in Clinical Trials. Second edition. Lippincott-Raven Publishers, Philadelphia 1197–1214
3. Bergner M, Bobbitt RA, Carter WB, Gilson BS (1976) The sickness impact profile: development and final revision of a health status measure. Med Care 14: 57–67
4. Björk S (1996) Ethical and medical basis of health care rationing. In: Spilker B (eds) Quality of Life and Pharmacoeconomics in Clinical Trials. Second edition. Lippincott-Raven Publishers, Philadelphia 729–739
5. Gabriel SE, Campion ME, O’Fallon WM (1994) A cost-utility analysis of misoprostol prophylaxis for rheumatoid arthritis patients receiving nonsteroidal antiinflammatory drugs. Arthritis Rheum. 37: 333–341